DOI: https://doi.org/10.26641/2307-0404.2017.3.111914

Risk factors, cardiohemodynamics and renal function state in patients with chronic heart failure and myocardial infarction in anamnesis.

O. V. Kuryata, A. A. Zabida, D. L. Chvora

Abstract


The importance of the problem of heart failure for modern medicine is due to its growing prevalence and poor prognosis, despite a tendency to decrease of deaths from major cardiovascular diseases: coronary heart disease (CHD) and arterial hypertension (AH). Objective: to evaluate the risk factors, the state of cardiac hemodynamics and kidney function in patients with chronic heart failure (CHF) and acute myocardial infarction (AMI) in history. A retrospective analysis of 144 case histories of patients with CHF with preserved systolic function, aged 40 to 80 years and with disease duration from 1 year to 10 years was made. The patients were divided into 2 groups depending on the presence of anamnestic data in favor of past AMI: group 1 – 35 patients (24%) with CHF and AMI in anamnesis, 2 group, 109 patients (75,7%) with CHF without AMI in anamnesis. It was found that prevalence and severity of hypertension as well as arrhythmia were not significantly different in patients of both age groups. Among patients with stable angina and CHF with preserved ejection fraction there was established a high prevalence of hypertension, diabetes and obesity. The presence of AMI in anamnesis was associated with worse control of hypertension on the background of normal indicators of lipidogram, compared to patients with CHF without AMI in anamnesis. There was established a higher incidence of revealing patients with impaired renal function among patients with CHF with a trend to increase of manifestations of chronic renal failure and hyperuricemia among patients with postinfarction cardiosclerosis, regardless of patients’ age.

Keywords


chronic heart failure; myocardial infarction; cardiohemodynamics; dyslipidemia; cardiorenal syndrome

Full Text:

PDF

References


Kuryata AV. [Interrelation of the state of erythro­cyte membranes with variants of left ventricular hyper­trophy in patients with essential hypertension]. Arkhyv klynycheskoy y éksperymentalʹnoy medytsyny. 2002;3:352-54. Russian.

Kuryata AV. [The relationship between the types of response of hemodynamics to physical activity and the morphofunctional state in young men with essential hy­per­tension]. Ukr. kardiolohichnyy zhurnal. 2003;5:56-59. Russian.

Tereschenko SN, Zhirov IV,RomanovaNV, et al. [The first Russian registry of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design] Ratsionalnaya farmakoterapiya v kardiologii. 2015;11(6):577-81. Russian.

Rebrova OYu. [Statistical analysis of medical data. Application of the STATISTIKA software package]. Media Sfera; 2002. Russian.

Stamler J, Vaccaro O, Neaton JD. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. J. Diabetes Care. 1993;16:434-44.

Montalescot G, Sechtem U, Achenbach S. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.

Lozano R. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380:2095-128.

Group KDIGOKBPW. Clinical practice guideline for the evaluation and management of blood pressure in chronic kidney disease. Kidney International Supple­ments. 2012;2(5):337-414.

Hyon K Curhan G. Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease. Circulation. 2007;116:894-900.

Jeremy S, Bock Stephen S. Cardiorenal synd­rome: New perspectives. European Heart Journal. 2010;121:2592-600.

Sarnak MJ, Levey AS, Schoolwerth AC. Kidney Disease as a Risk Factor for Development of Cardio­vascular Disease. Circulation. 2003;108:2154-69.

Anavekar NS, McMurray JJ, Velazquez EJ. Renal dys­function and cardiovascular outcomes after myocar­dial infarction.New England journal medicine. 2004;351(13):1285-95.

The European health report 2012: charting the way to well-being. WHO Regional Office forEurope. 2013;162.

Mak K-H, Bhatt DL, Shao M. The influence of body mass index on mortality and bleeding among patients with or at high risk of atherothrombotic disease. Eur. Heart J. 2009;30(7):857-65.

Wencker D. Acute cardio-renal syndrome: pro­gression from congestive heart failure to congestive kid­ney failure. Current Heart Faillure Report. 2007;4:134-38.


GOST Style Citations


  1. Курята А.В. Взаимосвязь состояния мембран эритроцитов с вариантами гипертрофии левого же­лудочка у больных гипертонической болезнью / А.В. Ку­рята // Архив клинич. и эксперим. медицины. –  2002. – № 3. – С. 352-354
  2. Курята А.В. Взаимосвязь типов реакции гемо­динамики на физическую нагрузку и морфофункцио­нального состояния у молодых мужчин с гипертони­ческой болезнью / А.В. Курята // Укр. кардіол. жур­нал. –  2003. – № 5. – С. 56-59.
  3. Первый российский регистр больных хрони­ческой сердечной недостаточностью и фибрилляцией предсердий (РИФ-ХСН): дизайн исследования / С.Н. Те­рещенко, И.В. Жиров, Н.В. Романова [и др.] // Рациональная фармакотерапия в кардиологии. – 2015. –  № 11(6). – C. 577-581.
  4. Реброва О.Ю. Статистический анализ меди­цинских данных. Применение пакета прикладных программ STATISTIKA / О.Ю. Реброва. – Москва: Медиа Сфера, 2002. – 312 с.
  5. Diabetes, other risk factors, and 12-year cardio­vascular mortality for men screened in the Multiple Risk Factor Intervention Trial / J. Stamler, O. Vaccaro, JD. Nea­ton [et al.] // Diabetes Care. – 1993. – N 16. – P. 434-444.
  6. ESC guidelines on the management of stable coronary artery disease: the Task Force on the mana­gement of stable coronary artery disease of the European Society of Cardiology / G. Montalescot, U. Sechtem, S. Achenbach [et al.] // Eur. Heart J. –  2013. –  N 34. – Р. 2949-3003. DOI: 10.1093/eurheartj/eht296.
  7. Global and regional mortality from 235 causes of death  for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 / R. Lozano, M. Naghavi, K. Foreman, [et al.] // Lancet. – 2012. – N 380. – Р. 2095–128. doi: 10.1016/S0140-6736(12)61728-0.
  8. Group KDIGOKBPW. Clinical practice guideline for the evaluation and management of blood pressure in chronic kidney disease / Kidney Inter. Supplements. – 2012. – Vol. 2, N 5. – P. 337-414. doi: 10.1053/j.ajkd.2013.03.018.
  9. Hyon K. Independent Impact of Gout on Mor­tality and Risk for Coronary Heart Disease / K. Hyon, G. Curhan // Circulation. –  2007. – Vol. 116. – Р. 894-900. doi: 10.1161/CIRCULATIONAHA.107.703389.
  10. Jeremy S. Cardiorenal syndrome: New perspectives / S. Jeremy, S. Bock Stephen // Eur. Heart J. – 2010. – Vol. 121. – P. 2592-2600. doi: 10.1161/CIRCULATIONAHA.109.886473.
  11. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease / M.J. Sarnak, A.S. Levey, A.C. Schoolwerth [et al.] // Circulation. – 2003. – Vol. 108. – P. 2154-2169. doi: 10.1161/01.HYP.0000102971.85504.7c.
  12. Renal dysfunction and cardiovascular outcomes after myocardial infarction / N.S. Anavekar, J.J. McMur­ray, E.J. Velazquez [et al.] // New Engl. J. Medicine. – 2004. – Vol. 351, N 13. – P. 1285-95. doi: 10.1056/NEJMoa041365.
  13. The European health report 2012: charting the way to well-being / Pre-public. copy // WHO Regional Office for Europe.-Copenhagen:Denmark, 2013. – 162 p.
  14. The influence of body mass index on mortality and bleeding among patients with or at high risk of atherothrombotic disease / K.-H. Mak, D.L. Bhatt, M. Shao [et al.] // Eur. Heart J. – 2009. – Vol. 30, N 7. – P. 857-865. DOI: 10.1093/eurheartj/ehp037.
  15. Wencker D. Acute cardio-renal syndrome: pro­gression from congestive heart failure to congestive kidney failure / D. Wencker // Current Heart Faillure Report. – 2007. – N 4. – Р. 134-138.